Revenue

With a $12M boost from a16z, Pryzm's AI is tackling the Pentagon's $900B procurement problem. Can software fix bureaucracy and secure America's edge?

A former oil driller pivots to advanced recycling, but can its plastics-to-fuel plant navigate financial risks and environmental scrutiny in Texas?

A landmark demonstration of 'unhackable' quantum communication on a live network signals a paradigm shift for protecting sensitive healthcare data.

A new partnership moves elite market data from raw feeds to interactive widgets, aiming to reshape advisor workflows and intensify WealthTech competition.

Marriott's latest survey and massive points giveaway reveal a strategic pivot to capture a historic shift in consumer spending from goods to travel.

HPP's routine preferred stock payout seems minor, but it reveals a deeper story of financial health and a strategic bet on a tech and media rebound.

iCIMS is #1 in the booming ATS market, but its real advantage isn't just AI. It's a validated, responsible approach that's winning over enterprise clients.

Cohere Health's new Policy Studio uses AI to digitize archaic medical policies, promising to cut costs, ease provider burden, and meet new regulations.

With a $24M Series A, AnySignal is modernizing mission-critical infrastructure. How will its software-defined radios reshape space and national security?

With its 2026 Investor Day nearing, PHINIA aims to prove its dual-path strategy is the key to powering a diverse, carbon-conscious industrial future.

Same-day delivery is no longer just about speed. It's enabling DTC brands to sell what was once unshippable, transforming product lines and logistics.

LRN appoints Bob Lemmond as CEO, a strategic move signaling a deeper push into data-driven ethics amid rising AI regulations and market complexity.

A Texas vehicle maker is deploying its Bitcoin into regulated DeFi. Is this a risky gamble or the new blueprint for corporate finance innovation?

Secure identity firm CLEAR lands a major CMS contract to overhaul Medicare.gov's login system, signaling a strategic push into the government sector.

Eli Lilly's takeover of Adverum signals a major push into ocular gene therapy. Can a one-time injection for vision loss disrupt a multi-billion dollar market?

FTI Consulting's new CHRO isn't just a leadership change. It's a strategic move to double down on the one asset that fuels its growth: its people.

A family-owned store's record safe sales reveal a story of niche retail, tax incentives, and a parent company's ambitious 'patriotic lifestyle' gamble.

A new federal hemp ban is set to fail, warns a CRS report. Experts say a lack of funding and data infrastructure could create a dangerous black market.

Beyond a simple product launch, a strategic acquisition is fueling innovations in drug delivery that could transform patient care for millions worldwide.

A famed NYC pub's arrival signals a new era for Atlanta's downtown, as the massive Centennial Yards project races to redefine the city for a global stage.